Search Results
Aug 28, 2026, 17:35 ET Five ways K-12 leaders can strengthen teacher recognition beyond appreciation weeks, according to new University of Phoenix white paper
Phoenix College of Doctoral Studies has published a new white paper, "Beyond Appreciation Weeks: Building Teacher Recognition Into the Everyday Work of K–12 Leadership," by Contessa Walker-Jackson, Ed.D., alumni fellow with the University's
More news about: University of Phoenix
Aug 28, 2026, 16:50 ET Trilogy Metals Announces Execution of Definitive Agreements for Strategic Equity Investment by the U.S. Department of War
continuing our work with South32, federal and state agencies, and Alaska Native communities to responsibly develop this exceptional district."George K. Kollitides II, Director of the Department of War's Economic Defense Unit, added: "Investing in the Upper Kobuk Mineral Projects demonstrates the War
More news about: Trilogy Metals Inc.
Aug 28, 2026, 16:19 ET Spoločnosť IGEL rozširuje možnosti koncových bodov o hardvér Teguar pre zdravotníctvo a priemyselné prostredie
IGEL®, globálna softvérová spoločnosť poskytujúca platformu IGEL Adaptive Secure Endpoint Platform™, dnes oznámila, že značka Teguar sa pripojila k ekosystému
More news about: IGEL
Aug 28, 2026, 16:15 ET Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Exchange Commission (SEC), including the risks and uncertainties described under the heading "Risk Factors" in our most recent Annual Report on Form 10-K or Quarterly Report, as such risks and uncertainties may be amended or supplemented by our other filings with the SEC . Any forward-looking statement
More news about: Nektar Therapeutics
Aug 28, 2026, 16:15 ET Energy Fuels Completes Acquisition of Australian Strategic Materials
actions or inactions; and the other factors described under the caption "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and Quarterly Report filed on Form 10-Q, which are available for review on EDGAR at
More news about: Energy Fuels Inc.
Aug 28, 2026, 14:38 ET 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-Q for the fiscal quarter ended June 30, 2026 and 10-K for the fiscal year ended December 31, 2025 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time
More news about: 10x Genomics, Inc.
Aug 28, 2026, 13:00 ET Lucid Adds New Leaders Across Commercial, Finance, and Marketing
factors discussed under the cautionary language and the Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025, subsequent Quarterly Reports on Form 10-Qs, Current Reports on Form 8-K, and other documents Lucid has filed or will file with the Securities and Exchange Commission.
More news about: Lucid Group
Aug 28, 2026, 11:46 ET New Batch of Life-Size Animatronic Gremlins Unleashed This Halloween
characters bring unforgettable fun into the holiday season. Available in-store and online at The Home Depot.Gremlins is available to own on 4K UHD and Gremlins: The New Batch is available to own on Blu-ray.About Gemmy Industries Gemmy Industries is a leader in the
More news about: Gemmy Industries
Aug 28, 2026, 11:08 ET Corvex Appoints Garrett Brams to Lead Data Center Infrastructure Development
the risks and uncertainties described in the Company's SEC reports, and under the heading "Risk Factors" in its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available at
More news about: Corvex
Aug 28, 2026, 11:00 ET Top 10 Real Estate News: August's Interesting Real Estate News
Florida, Alaska, Nevada, Tennessee, Texas, New Hampshire, Mississippi, and Illinois.US Real Estate Under $250K Is Slow – Over $750K Is SurgingIn July, the
More news about: Top Ten Real Estate Deals
Aug 28, 2026, 10:01 ET Social and Emotional Learning Market worth $18.46 billion by 2032 - Report by MarketsandMarkets™
gaining strong momentum as education systems increasingly prioritise student well-being alongside academic achievement. SEL is being widely adopted across K–12 schools, higher education institutions, and even workplace learning environments to help individuals manage emotions, build resilience, and develop
More news about: MarketsandMarkets
Aug 28, 2026, 09:19 ET AUKČNÝ DOM JULIEN'S AUCTIONS PREDSTAVUJE „KRÁĽA KAIDŽÚ: KOLEKCIA ODKAZU SOMPOTA SANDSA"
zberateľské predmety Kaidžú zo 70. rokov 20 storočia vrátane Bullmark, Bandai, Popy a ďalších, zbierka divadelných plagátov vrátane ručne maľovaných plagátov k japonským filmom z rokov 1962/63 s podpismi Akiru Kurosavu, Iširó Hondu, Eidžiho Cuburaju a ďalších legendárnych režisérovEXKLUZÍVNA ŽIVÁ
More news about: Julien's Auctions
Aug 28, 2026, 09:00 ET FLOWERS FOODS DECLARES QUARTERLY DIVIDEND
performance, liquidity, and achievements to differ materially from those projected are discussed in our Annual Report on Form 10-K for the year ended January 3, 2026 (the "Form 10-K") and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission ("SEC") and may include, but are not
More news about: Flowers Foods, Inc.
Aug 28, 2026, 09:00 ET China's Robot Boom Is Raising Security Fears as the US Robotics Race Accelerates
expected to attend. For the first time, the company plans to bring its entire lineup together under one roof, including the all-new K7 and K5 Autonomous Security Robots, K1 stationary security systems, the H1 Augmented Security Agent prototype, and Signals, its forthcoming command interface and operational
More news about: Market News Updates
Aug 28, 2026, 09:00 ET WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Offering
Tenon's actual results to be materially different than those expressed in any forward-looking statements, please review Tenon's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updated from time to time in our Form 10-Q filings and in our other public filings on file with the SEC
More news about: WallachBeth Capital LLC
Aug 28, 2026, 08:30 ET Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
"Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Novavax's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (SEC). We caution
More news about: Novavax, Inc.
Aug 28, 2026, 07:55 ET Procam launches 'HDOR - 100 Days of Running' in a whole new avatar turning 100 days of movement into habits for life
running movement in India, Procam International's Big 4 – Tata Mumbai Marathon, Vedanta Delhi Half Marathon, Tata Consultancy Services World 10K and Tata Steel World 25K Kolkata— are global leaders in their respective distances. They have ushered in a running revolution that has helped redefine the health,
More news about: Procam International
Aug 28, 2026, 07:31 ET BRC Group Holdings, Inc. Announces Full Redemption of 6.50% Senior Notes Due 2026
filed with the Securities and Exchange Commission (SEC), including, without limitation, the risks described in the Company's 2025 Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Forward-looking
More news about: BRC Group Holdings, Inc.
Aug 28, 2026, 07:30 ET Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
drug development company, based in Sydney, Australia. The Company's lead asset, paxalisib, is an investigational brain penetrant inhibitor of the PI3K/Akt/mTOR pathway, which is being developed to treat multiple forms of cancer. Licensed from Genentech in late 2016, paxalisib is or has been the subject
More news about: Kazia Therapeutics Limited
Aug 28, 2026, 07:15 ET La FDA aprueba Mounjaro (tirzepatida) de Lilly para reducir el riesgo cardiovascular en adultos con diabetes tipo 2
estos y otros riesgos e incertidumbres que podrían hacer que los resultados reales difirieran de las expectativas de Lilly, consulta el Formulario 10-K y el Formulario 10-Q presentados por Lilly ante la Comisión del Mercado de Valores de Estados Unidos. Salvo que lo exija la ley, Lilly no asume ninguna
More news about: Eli Lilly and Company
Aug 28, 2026, 07:00 ET FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Aug 28, 2026, 06:01 ET Kunlun Capital-Backed InfiMaker Surpasses US$4 Million in Kickstarter Pledges, Following US$1.5 Million First‑Day Debut
milestones following the launch of its K1 desktop five‑axis CNC machine: its Kickstarter campaign has surpassed US$4 million in pledges, and it has completed a new funding round of tens of millions of U.S. dollars from IDG Capital. InfiMaker officially launched the K1 on Kickstarter on August 11, Pacific
More news about: Kunlun Capital
Aug 28, 2026, 05:32 ET La Food and Drug Administration statunitense ha accettato la domanda di autorizzazione per un nuovo farmaco denominato "K-911", destinato a pazienti affetti da glaucoma e ipertensione oculare
NAGOYA, Giappone, 28 agosto 2026 /PRNewswire/ -- Kowa Company, Ltd. (di seguito "Kowa") sta sviluppando K-911 per l'indicazione della riduzione della pressione intraoculare (IOP) nei pazienti con glaucoma o ipertensione oculare tramite la sua società affiliata
More news about: Kowa Company Ltd.
Aug 28, 2026, 04:25 ET The Anime "KAGURABACHI" Casts Miku Ito as Hinao and Miyari Nemoto as Char Kyonagi; Cast Comments, Character Visuals & Trailers Revealed
protection and introduced her to Chihiro and the others.Hinao Character Trailer:English:https://youtu.be/K2KIkl-yF1oJapanese:https://youtu.be/ZEBG6_z4T-Y
More news about: CyberAgent, Inc.
Aug 28, 2026, 04:14 ET La demande d'autorisation de mise sur le marché du « K-911 », destiné aux patients atteints de glaucome et d'hypertension oculaire, a été acceptée par la Food and Drug Administration (FDA) aux États-Unis
Japon, 28 août 2026 /PRNewswire/ -- La société Kowa Company, Ltd. (ci-après dénommée « Kowa ») développe le K-911 pour le traitement visant à réduire la pression intraoculaire (PIO) chez les patients atteints de glaucome ou d'hypertension oculaire, par l'intermédiaire
More news about: Kowa Company Ltd.